HCA Healthcare, Inc. (NYSE:HCA) Holdings Decreased by First Eagle Investment Management LLC

First Eagle Investment Management LLC decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,493,039 shares of the company’s stock after selling 9,500 shares during the quarter. HCA Healthcare comprises 3.2% of First Eagle Investment Management LLC’s holdings, making the stock its 5th biggest position. First Eagle Investment Management LLC owned approximately 1.72% of HCA Healthcare worth $1,443,523,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in HCA. Vanguard Group Inc. boosted its holdings in shares of HCA Healthcare by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after acquiring an additional 60,304 shares during the last quarter. Sanders Capital LLC raised its stake in shares of HCA Healthcare by 4.2% during the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after buying an additional 456,738 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of HCA Healthcare by 1.7% in the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock worth $2,757,181,000 after buying an additional 170,560 shares during the last quarter. Royal Bank of Canada raised its position in HCA Healthcare by 35.7% during the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after acquiring an additional 1,183,890 shares in the last quarter. Finally, Capital World Investors grew its stake in shares of HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after purchasing an additional 1,019,750 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock valued at $6,407,273 over the last quarter. 1.60% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

NYSE:HCA opened at $399.89 on Thursday. The company’s 50-day moving average is $367.24 and its two-hundred day moving average is $339.56. The firm has a market capitalization of $104.74 billion, a price-to-earnings ratio of 19.93, a PEG ratio of 1.46 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $404.90.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.29 earnings per share. Analysts forecast that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a dividend of $0.66 per share. The ex-dividend date is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.66%. HCA Healthcare’s payout ratio is currently 13.16%.

Analysts Set New Price Targets

Several brokerages recently weighed in on HCA. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Royal Bank of Canada increased their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Morgan Stanley started coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price objective on the stock. Robert W. Baird began coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price target for the company. Finally, Wells Fargo & Company boosted their price objective on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 30th. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $359.89.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.